Three objectives underpin our research programme

Improved Donation and Donor Care

It is imperative to gain a deeper understanding into the factors impacting our donors and insight will provide an evidence base from which to develop and improve blood collection policies, testing algorithms and clinical guidelines.

Progressive Blood Service

We must future-proof our blood service in relation to changing technologies, blood demands and blood component usage.

The development of regenerative medicines and other cellular solutions to disease management requires translation from the research benches to GMP production.

Clinical Leadership

Research leadership requires participation in national and international networks, and collaboration with clinical colleagues, international blood services and commercial partners, for research endeavours and clinical trials.

IBTS Research & Development Strategy 2021 to 2023